ATYR vs J · rev $190.0K vs P/E 36, rev $4.08B
aTyr Pharma, Inc. (ATYR) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
aTyr Pharma, Inc. (ATYR) is a biotechnology company listed on US.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ATYR revenue for 2025-09-30 was $190.0K. Net income was -$25.7M. ATYR currently screens at market cap $471.7M.
Latest reported J revenue for 2026-06-26 was $4.08B. Net income was $136.6M. Revenue was down 41.7% from 2026-03-27 to 2026-06-26. J currently screens at market cap $14.40B and trailing P/E 36.0.
ATYR currently screens at market cap $471.7M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ATYR and J stock pages for the full models.
Not investment advice.